A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma

Author： Griffin Patrick T.   Ho Viet Q.   Fulp William   Nishihori Taiga   Shain Kenneth H.   Alsina Melissa   Baz Rachid C.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|20|3622-3630

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3622-3630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide benefits patients with refractory multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Carfilzomib: In Relapsed, or Relapsed and Refractory, Multiple Myeloma

By McCormack Paul L.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 2023-2032

Adis International

Access to resources Recommend Favorite

Role of Active Drug Transporters in Refractory Multiple Myeloma

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 218-224

Bentham Science Publishers

Access to resources Recommend Favorite

High-dose chemotherapy + stem cells for multiple myeloma

By  

Inpharma, Vol. 1, Iss. 1387, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Lenalidomide: A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma

By Scott Lesley J.   Lyseng-Williamson Katherine A.  

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 625-649

Adis International

Access to resources Recommend Favorite